Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
+$784M |
| 2 |
Amgen
AMGN
|
+$695M |
| 3 |
Eli Lilly
LLY
|
+$512M |
| 4 |
Apple
AAPL
|
+$485M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$471M |
Top Sells
| 1 |
Adobe
ADBE
|
+$935M |
| 2 |
NVIDIA
NVDA
|
+$837M |
| 3 |
TJX Companies
TJX
|
+$533M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$364M |
| 5 |
Starbucks
SBUX
|
+$357M |
Sector Composition
| 1 | Technology | 35.94% |
| 2 | Healthcare | 18.89% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Exact Sciences
EXAS
$10.4B
| $655K | ﹤0.01% |
15,500
-328
| -2% | -$13.9K |
|
1852
Keros Therapeutics
KROS
$636M
| $654K | ﹤0.01% |
14,307
+4,475
| +46% | +$204K |
|
1853
Hope Bancorp
HOPE
$1.41B
| $653K | ﹤0.01% |
60,814
-590
| -1% | -$6.34K |
|
1854
Mercury Systems
MRCY
$4.3B
| $649K | ﹤0.01% |
24,025
-296
| -1% | -$8K |
|
1855
Mercury Insurance
MCY
$4.31B
| $646K | ﹤0.01% |
12,161
-137
| -1% | -$7.28K |
|
1856
Powell Industries
POWL
$3.34B
| $645K | ﹤0.01% |
4,500
-847
| -16% | -$121K |
|
1857
RxSight
RXST
$410M
| $643K | ﹤0.01% |
10,700
-154
| -1% | -$9.26K |
|
1858
Perdoceo Education
PRDO
$2.16B
| $643K | ﹤0.01% |
29,952
-329
| -1% | -$7.06K |
|
1859
Klaviyo
KVYO
$9.35B
| $642K | ﹤0.01% |
25,800
-192
| -0.7% | -$4.78K |
|
1860
Clear Secure
YOU
$3.48B
| $641K | ﹤0.01% |
34,291
-80,991
| -70% | -$1.51M |
|
1861
RELX
RELX
$82.4B
| $641K | ﹤0.01% |
13,975
| – | – |
|
|
CFB
1862
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $641K | ﹤0.01% |
45,729
-2,407
| -5% | -$33.7K |
|
1863
Global Net Lease
GNL
$1.81B
| $638K | ﹤0.01% |
86,788
-1,010
| -1% | -$7.43K |
|
1864
Indivior
INDV
$3.04B
| $636K | ﹤0.01% |
40,546
-399,575
| -91% | -$6.27M |
|
1865
Alkami Technology
ALKT
$2.62B
| $631K | ﹤0.01% |
22,175
-151
| -0.7% | -$4.3K |
|
1866
Phreesia
PHR
$1.52B
| $628K | ﹤0.01% |
29,631
-7,470
| -20% | -$158K |
|
1867
Business First Bancshares
BFST
$729M
| $628K | ﹤0.01% |
28,895
-1,165
| -4% | -$25.3K |
|
1868
Recursion Pharmaceuticals
RXRX
$1.98B
| $626K | ﹤0.01% |
83,628
+21,206
| +34% | +$159K |
|
1869
Xerox
XRX
$456M
| $626K | ﹤0.01% |
53,856
-589
| -1% | -$6.84K |
|
1870
International Money Express
IMXI
$430M
| $623K | ﹤0.01% |
29,875
-2,213
| -7% | -$46.1K |
|
1871
Supernus Pharmaceuticals
SUPN
$2.59B
| $622K | ﹤0.01% |
23,254
-271
| -1% | -$7.25K |
|
1872
Arvinas
ARVN
$575M
| $621K | ﹤0.01% |
23,365
-9,064
| -28% | -$241K |
|
1873
Cannae Holdings
CNNE
$1.1B
| $620K | ﹤0.01% |
34,196
-337
| -1% | -$6.12K |
|
|
LSXMA
1874
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $620K | ﹤0.01% |
+28,000
| New | +$620K |
|
1875
Enact Holdings
ACT
$5.71B
| $620K | ﹤0.01% |
20,221
-153
| -0.8% | -$4.69K |
|